Melissa Lechner
Lead, Onco-Endocrinology Program · UCLA David Geffen School of Medicine/UCLA Medical Center
Credentials: · · · · ·
History
- 2014–2018
Brigham and Women’s Hospital and Boston Children’s Hospital
- 2002–2006
University of California, Berkeley, Berkeley, CA
Research
The Journal of Immunology · 2010 · First of 3 authors · 500 citations
Review · Journal of the National Comprehensive Cancer Network · 2022 · 415 citations
Journal of Immunotherapy · 2013 · First of 9 authors · 290 citations
21 papers · 5 as a fellow
16 papers
15 papers
- KT
8 papers · 2 as a fellow
7 papers
5 papers
5 papers
4 papers · 4 as a fellow
Grants
- 2026–2031
Leveraging JAK Inhibitors to Halt Autoimmune Attack Induced by Immune Checkpoint Inhibitors
National Institute of Allergy and Infectious Diseases · U01
Contact PI · $1.2M · University of California Los Angeles
- 2024–2029
Identifying New Immunotherapeutic Targets for Endocrine Autoimmunity.
National Institute of Allergy and Infectious Diseases · U19
Project lead · $690.2K · University of California Los Angeles
- 2021–2026
Mechanisms of Thyroid Autoimmunity in Checkpoint Immunotherapy
National Institute of Diabetes and Digestive and Kidney Diseases · K08
Contact PI · $878.5K · University of California Los Angeles